Aries Pharmaceutical

Aries Pharmaceuticals was a specialty pharmaceutical company dedicated to commercializing innovative gastroenterology products in the United States. Established as the US commercial arm of Cosmo Pharmaceuticals, the company focused on improving the quality of care for patients undergoing endoscopic procedures and treating gastrointestinal infections. Its lead products included Eleview, a submucosal injectable composition for lesion resection, and Aemcolo, a locally acting antibiotic for travelers' diarrhea. In 2019, following a strategic shift by its parent company, Aries' commercial operations were restructured, and its product rights were licensed to partners like Medtronic and RedHill Biopharma. The company was headquartered in San Diego, California.